News and Events
Stay up to date with news and events
Roche provides an update on tominersen: What’s next for this huntingtin-lowering drug?
This week, we heard an update from Roche about their huntingtin-lowering therapy, tominersen, currently being tested in the GENERATION HD2 trial. An independent data monitoring…
Knockouts for the win: how expanding CAGs drive disease
Huntington’s disease (HD) is caused by extra repeats of the DNA letters CAG within the genetic code of the huntingtin gene. We used to think…
Piecing It Back Together: Growing new neurons for Huntington’s disease
We often think of the adult brain like a completed jigsaw puzzle—once all the pieces are in place, that’s it. If a few pieces go…
Stars in the Sky: Psychosis in Huntington’s Disease
Imagine battling a disease that not only affects your body but also causes your mind to lose touch with reality, making it hard to see…
Do Antidepressants Affect Cognitive Decline? What Huntington’s Disease Families Should Know
Two recent studies offer fresh insights into how antidepressants, often prescribed to help manage mood and anxiety, are prescribed in Huntington’s disease (HD) and might…